Mitsuho Imai
Medical Oncologist National Cancer Center Hospital East
I am one of the core members of SCRUM-Japan, which conducts clinical trials for the development of pharmaceuticals and medical devices for cancer treatment globally, from clinical trial planning to obtaining regulatory approval while organizing about 200 facilities nationwide.
I am an oncologist specializing in gastroenterology. I completed my clinical training at a general hospital specializing in oncology in Tokyo. Following that, I researched cancer microenvironment and autophagy during my doctoral program at the University of Tokyo, and lncRNA and epigenetics as a post-doctoral fellow at UCSF.
I am a member of a working group for the development of the infrastructure for cancer genetic medicine under domestic insurance approval, and I am promoting the development project while providing specialized outpatient care at one of the 12 hospitals designated by the Japanese government as a core genome center.
Seminars
- Lessons from domestic CDx approvals, such as BRAF, and integration of complex biomarkers including TME analysis
- Opportunities and challenges in Japan’s genomic medicine landscape, regulatory approval, and clinical adoption